Litha Healthcare was founded in 2006 and is a diversified healthcare business providing services, products, and solutions to public and private hospitals and government healthcare programmes in Southern Africa. The group comprises three divisions, namely Litha Biotech (biotechnology/vaccines), Litha Medical (medical devices) and Litha Pharma (pharmaceuticals).
Major shareholders at 3 July 2012:
Paladin Labs - 44.52%
Visio Capital - 13.79%
Paladin Labs - 44.52%
Visio Capital - 13.79%
Blackstar Investors Plc - 12.75%
Current share price: R3.60
P/E ratio: 11.3
Rock Capital's recommendation: BUY
Target R5.15
EPS growth 29%
Sources:
PSG Online
Standard Bank Share Trading
No comments:
Post a Comment